{"id":"https://openalex.org/W7212224599","doi":"https://doi.org/10.17615/jc76-p776","title":"Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial.","display_name":"Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial.","publication_year":2026,"publication_date":"2026-09-11","ids":{"openalex":"https://openalex.org/W7212224599","doi":"https://doi.org/10.17615/jc76-p776"},"language":"en","primary_location":{"id":"doi:10.17615/jc76-p776","doi":"https://doi.org/10.17615/jc76-p776","is_oa":true,"landing_page_url":"https://doi.org/10.17615/jc76-p776","pdf_url":null,"source":{"id":"https://openalex.org/S7407051488","display_name":"UNC Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"},"volume":null,"type":"article","indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.17615/jc76-p776","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017731236","display_name":"Jennifer B. Green","orcid":"https://orcid.org/0000-0002-9967-5352","observed_orcids":["https://orcid.org/0000-0002-9967-5352"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Green, Jennifer B","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043842967","display_name":"Johannes F.E. Mann","orcid":"https://orcid.org/0000-0002-3154-5332","observed_orcids":["https://orcid.org/0000-0002-3154-5332"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mann, Johannes F E","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052649260","display_name":"MEIKE DANIELA BRINKER","orcid":"https://orcid.org/0000-0002-1560-9535","observed_orcids":["https://orcid.org/0000-0002-1560-9535"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brinker, Meike","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5138654725","display_name":"Margarida Seco","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seco, Margarida","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091479388","display_name":"C. Scott","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Scott, Charlie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085592050","display_name":"Peter R Rossing","orcid":"https://orcid.org/0000-0002-1531-4294","observed_orcids":["https://orcid.org/0000-0002-1531-4294","https://orcid.org/0009-0004-5073-0009"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rossing, Peter","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1531-4294","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031624913","display_name":"Hiddo J.L. Heerspink","orcid":"https://orcid.org/0000-0002-3126-3730","observed_orcids":["https://orcid.org/0000-0002-3126-3730"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Heerspink, Hiddo J L","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3126-3730","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061881316","display_name":"Muthiah Vaduganathan","orcid":"https://orcid.org/0000-0003-0885-1953","observed_orcids":["https://orcid.org/0000-0003-0885-1953"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vaduganathan, Muthiah","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0885-1953","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5122009567","display_name":"Li Li","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Li, Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089305017","display_name":"Rajiv Agarwal","orcid":"https://orcid.org/0000-0001-8355-7100","observed_orcids":["https://orcid.org/0000-0001-8355-7100","https://orcid.org/0000-0002-3146-7231"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Agarwal, Rajiv","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8355-7100","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038617498","display_name":"Katja Rohwedder","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rohwedder, Katja","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045489578","display_name":"Julio Rosenstock","orcid":"https://orcid.org/0000-0001-8324-3275","observed_orcids":["https://orcid.org/0000-0001-8324-3275"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rosenstock, Julio","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8324-3275","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036113498","display_name":"Masaomi Nangaku","orcid":"https://orcid.org/0000-0001-7401-2934","observed_orcids":["https://orcid.org/0000-0001-7401-2934"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nangaku, Masaomi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050076657","display_name":"Janet B. McGill","orcid":"https://orcid.org/0000-0002-6228-6521","observed_orcids":["https://orcid.org/0000-0002-6228-6521"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"McGill, Janet B","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6228-6521","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009128263","display_name":"Amy K. Mottl","orcid":"https://orcid.org/0000-0002-4258-1726","observed_orcids":["https://orcid.org/0000-0002-4258-1726"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mottl, Amy K","raw_affiliation_strings":["University of North Carolina at Chapel Hill"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5121987049","display_name":"Na Li","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Li, Na","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.6874391,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.7714999914169312,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.7714999914169312,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.1729000061750412,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.007000000216066837,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/finerenone","display_name":"finerenone","score":0.9869999885559082},{"id":"https://openalex.org/keywords/empagliflozin","display_name":"empagliflozin","score":1.0},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.906000018119812},{"id":"https://openalex.org/keywords/albuminuria","display_name":"albuminuria","score":0.8669999837875366},{"id":"https://openalex.org/keywords/albumin-creatinine-ratio","display_name":"albumin-creatinine ratio","score":0.9129999876022339},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.902999997138977},{"id":"https://openalex.org/keywords/baseline-hba1c","display_name":"baseline HbA1c","score":0.8790000081062317},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6010000109672546},{"id":"https://openalex.org/keywords/glomerular-hyperfiltration","display_name":"glomerular hyperfiltration","score":0.6370000243186951},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate","display_name":"estimated glomerular filtration rate","score":0.7480000257492065},{"id":"https://openalex.org/keywords/hba1c-reduction","display_name":"HbA1c reduction","score":0.6240000128746033},{"id":"https://openalex.org/keywords/kidney-disease-progression","display_name":"kidney disease progression","score":0.35600000619888306},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.3310000002384186}],"concepts":[{"id":"https://openalex.org/C2775887513","wikidata":"https://www.wikidata.org/wiki/Q5373824","display_name":"Empagliflozin","level":4,"score":0.9793000221252441},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9013000130653381},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.7150999903678894},{"id":"https://openalex.org/C68443243","wikidata":"https://www.wikidata.org/wiki/Q2786686","display_name":"Quartile","level":3,"score":0.669700026512146},{"id":"https://openalex.org/C2776174234","wikidata":"https://www.wikidata.org/wiki/Q974792","display_name":"Albuminuria","level":3,"score":0.6366999745368958},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.564300000667572},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5220000147819519},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.43799999356269836},{"id":"https://openalex.org/C3018260909","wikidata":"https://www.wikidata.org/wiki/Q1322871","display_name":"Exploratory analysis","level":2,"score":0.4205999970436096},{"id":"https://openalex.org/C2777422806","wikidata":"https://www.wikidata.org/wiki/Q409898","display_name":"Dapagliflozin","level":4,"score":0.39309999346733093},{"id":"https://openalex.org/C12725497","wikidata":"https://www.wikidata.org/wiki/Q810247","display_name":"Baseline (sea)","level":2,"score":0.39149999618530273},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.37770000100135803},{"id":"https://openalex.org/C2777538456","wikidata":"https://www.wikidata.org/wiki/Q311213","display_name":"Glycated hemoglobin","level":4,"score":0.34860000014305115},{"id":"https://openalex.org/C2777693530","wikidata":"https://www.wikidata.org/wiki/Q6594689","display_name":"Benzhydryl compounds","level":4,"score":0.34689998626708984},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.3224000036716461},{"id":"https://openalex.org/C2781203188","wikidata":"https://www.wikidata.org/wiki/Q1676817","display_name":"Microalbuminuria","level":3,"score":0.303600013256073},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.27639999985694885},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.27410000562667847},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.2718999981880188},{"id":"https://openalex.org/C2909938374","wikidata":"https://www.wikidata.org/wiki/Q311213","display_name":"Glycated haemoglobin","level":4,"score":0.2628999948501587},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.2614000141620636}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.17615/jc76-p776","doi":"https://doi.org/10.17615/jc76-p776","is_oa":true,"landing_page_url":"https://doi.org/10.17615/jc76-p776","pdf_url":null,"source":{"id":"https://openalex.org/S7407051488","display_name":"UNC Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"doi:10.17615/jc76-p776","doi":"https://doi.org/10.17615/jc76-p776","is_oa":true,"landing_page_url":"https://doi.org/10.17615/jc76-p776","pdf_url":null,"source":{"id":"https://openalex.org/S7407051488","display_name":"UNC Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4414340936","https://openalex.org/W7108225169","https://openalex.org/W4415966725","https://openalex.org/W7163903915","https://openalex.org/W4414331619","https://openalex.org/W7140278770","https://openalex.org/W7163709304","https://openalex.org/W4407265667","https://openalex.org/W7140282891","https://openalex.org/W7220369167"],"abstract_inverted_index":{"Aims:":[0],"This":[1],"prespecified":[2],"analysis":[3],"evaluated":[4],"whether":[5],"the":[6],"safety":[7],"and":[8,12,27,34,54,91,100,115,137,156,161,169,174,178,232,245,253],"efficacy":[9],"of":[10,40,257],"finerenone":[11,244],"a":[13,35,214],"sodium-glucose":[14],"cotransporter":[15],"2":[16,32,152],"inhibitor":[17],"(SGLT2i)":[18],"combination":[19,113,203],"vary":[20],"by":[21],"baseline":[22,76,89,189,208],"glycated":[23],"haemoglobin":[24],"(HbA1c).":[25],"Materias":[26],"Methods:":[28],"Adults":[29],"with":[30,112,127,130,243,251],"type":[31],"diabetes":[33],"urinary":[36],"albumin-to-creatinine":[37],"ratio":[38],"(UACR)":[39],"100":[41],"-":[42],"<":[43,56],"5000":[44],"mg/g,":[45],"estimated":[46],"glomerular":[47],"filtration":[48],"rate":[49],"(eGFR)":[50],"30-90":[51],"mL/min/1.73":[52,102,105],"m2":[53,103],"HbA1c":[55,82,90,110,143,191,211,258],"11%":[57],"(<":[58],"97":[59],"mmol/mol)":[60],"were":[61,97,140],"randomised":[62],"(1:1:1)":[63],"to":[64,213],"once-daily":[65],"finerenone,":[66],"empagliflozin":[67,116],"or":[68],"combination.":[69],"Primary":[70],"outcome":[71],"was":[72,83,195,254],"UACR":[73,206,249],"change":[74,120,129],"from":[75,188,207],"at":[77,192],"Day":[78,108,193,201],"180.":[79],"Results:":[80],"Baseline":[81],"available":[84],"for":[85],"781/800":[86],"CONFIDENCE":[87],"participants;":[88],"eGFR":[92],"mean":[93,119],"values":[94],"(standard":[95],"deviation)":[96],"7.3%":[98],"(1.2%)":[99],"54.2":[101],"(17.1":[104],"m2).":[106],"At":[107,200],"180,":[109,202],"decreased":[111],"therapy":[114,204],"(both":[117],"least-squares":[118],"-0.1%":[121],"[95%":[122,221],"confidence":[123],"interval":[124],"-0.2,":[125],"-0.0]),":[126],"no":[128],"finerenone.":[131],"In":[132],"total,":[133],"212,":[134],"190,":[135],"188":[136],"191":[138],"participants":[139],"included":[141],"in":[142,190,197,209,236],"Quartiles":[144,237],"1":[145],"(HbA1c":[146,153,166,180],"\u2264":[147,157,162,170,175],"6.4%":[148],"[\u2264":[149],"46":[150,160],"mmol/mol]),":[151,164,185],">":[154,167,181],"6.4":[155],"7.1%":[158],"[>":[159,172,183],"54":[163,173],"3":[165],"7.1":[168],"7.9%":[171,182],"63":[176,184],"mmol/mol])":[177],"4":[179],"respectively.":[186],"Change":[187],"180":[194],"greatest":[196],"Quartile":[198],"4.":[199],"reduced":[205,248],"all":[210],"quartiles":[212],"greater":[215],"extent":[216],"than":[217],"either":[218],"monotherapy":[219,252],"(mean":[220],"CI]":[222],"-53%":[223],"[-63,":[224],"-42],":[225,235],"-47%":[226],"[-57,":[227],"-34],":[228],"-63%":[229],"[-70,":[230],"-54]":[231],"-55%":[233],"[-65,":[234],"1-4,":[238],"respectively).":[239],"Conclusion:":[240],"Simultaneous":[241],"initiation":[242],"an":[246],"SGLT2i":[247],"compared":[250],"well-tolerated":[255],"irrespective":[256],"levels.":[259]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2026-09-12T00:00:00"}